Peptides are targeted signals: they send instructions to specific cells, tissues, or hormones rather than acting globally
TB-500 corresponds to the active region of Thymosin Beta-4, a naturally occurring 43-amino-acid protein involved in regulating the actin cytoskeleton
Key Peptides That Support Prolotherapy It is recommended to use a combination of injectable peptides to enhance the benefits of prolotherapy, including: GLOW (BPC-157 + TB-500 + GHK-Cu) GLOW is a proprietary blend of three synergistic peptides designed to promote comprehensive tissue regeneration: BPC-157 (5mg) : Enhances tendon and ligament healing, reduces inflammation, improves angiogenesis TB-500 (10mg) : Supports cell migration, modulates inflammation, prevents scar tissue GHK-Cu (27mg) : Stimulates collagen and elastin, improves skin and soft tissue repair GLOW is ideal in the early healing phase post-prolotherapy to amplify fibroblast activity and new capillary formation , both crucial for regenerative success
The American Medical Association's code of ethics is clear: clinical decisions must be based on 'sound scientific evidence'
In clinical trials for type 2 diabetes, fatigue was not identified as a frequent side effect occurring in more than 5% of participants
